| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner | 10% Owner +1 more
17 companies
Baker Bros. Advisors LP is a Director, 10% Owner at INCY with holdings across 17 companies. Recent SEC Form 4 filings include 62 buys and 8 sells.
Estimated insider holdings value: $5263.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2017 | ONC Beone Medicines Ltd. | Director, 10% Owner | Buy | 176,056 | $71.00 | $12,499,976.00 | +4.8% | |
| Jan 9, 2017 | NGNE Neurogene Inc. | 10% Owner | Buy | 398,062 | $17.18 | $6,836,812.66 | +0.4% | |
| Sep 20, 2016 | NGNE Neurogene Inc. | 10% Owner | Buy | 2,783,605 | $12.25 | $34,110,452.49 | +31.4% | |
| Aug 16, 2016 | BCRX Biocryst Pharmaceuticals Inc | 10% Owner | Sell | 4,046,590 | $5.00 | $20,251,102.77 | -8.2% | |
| Aug 10, 2016 | ACAD Acadia Pharmaceuticals Inc | Director, 10% Owner | Buy | 1,303,030 | $33.00 | $42,999,990.00 | +5.4% | |
| May 11, 2016 | NTLA Intellia Therapeutics, Inc. | Former 10% Owner | Buy | 200,000 | $18.00 | $3,600,000.00 | +23.2% | |
| Apr 1, 2016 | ACAD Acadia Pharmaceuticals Inc | Director, 10% Owner | Buy | 1,449,090 | $27.08 | $39,239,808.14 | +0.7% | |
| Mar 16, 2016 | NGNE Neurogene Inc. | 10% Owner | Buy | 471,667 | $7.99 | $3,770,636.35 | +1.3% | |
| Feb 5, 2016 | BCRX Biocryst Pharmaceuticals Inc | 10% Owner | Buy | 45,000 | $6.33 | $284,656.50 | +0.4% | |
| Feb 4, 2016 | BCRX Biocryst Pharmaceuticals Inc | 10% Owner | Buy | 207,715 | $6.43 | $1,336,586.04 | +0.5% |